Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Partnership With Bitcoin Giant NYDIG Will Enable New York Yankees Employees to Convert Salaries To BTC
  2. Bitcoin Could See Santa Claus Rally Before Moving to $65,000 Next Year, Says Analyst Who Called 2018’s Market Bottom
  3. Vipshop Holdings Still Up On Improved Q2 Results
  4. ‘Diamond Hands’ Tesla Still HODLing Over 10,000 BTC, Q4 2022 Report Reveals
  5. $BTC: US Space Force Major’s Book Highlights Bitcoin’s Significance for National Security